LENZ
LENZ Therapeutics Inc
3.50$
-2.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -13,754.5% | – | -230.2% | -68.7% | -2,079.7% | -1,766.5% | -705.7% | -530.4% | |
| – | – | – | – | – | 37.9% | – | 0.4% | 1.0% | -207.9% | 5.8% | 2.0% | -13.8% | |
| – | – | – | – | – | 2,469.7% | – | 56.9% | 27.8% | 231.6% | 227.2% | 81.5% | 74.2% | |
| – | – | – | – | – | 5,040.9% | – | 28.6% | 42.4% | -31.7% | 177.7% | -205.0% | -14.3% | |
| – | – | – | – | – | 225.8% | – | 4.8% | 3.5% | 2.4% | 0.9% | 0.3% | 2.4% | |
| – | – | – | – | – | -17,974.2% | – | -8.3% | -34.7% | -5,655.5% | 1,744.4% | 688.2% | -108.2% | |
| – | – | – | – | – | – | – | – | 1.8% | – | – | – | – | |
| – | – | – | – | – | 80.3% | – | 529.8% | 4.8% | 7,721.3% | 0.7% | 7.2% | 575.7% | |
| – | – | – | – | – | -31,648.5% | – | 291.3% | -98.6% | -13.9% | -21.4% | -10.3% | -62.9% | |
| – | – | – | – | – | -13,980.3% | – | -235.0% | -72.2% | -2,082.1% | -1,767.5% | -706.0% | -532.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.